Uss Investment Management LTD Horizon Therapeutics Public LTD CO Transaction History

Uss Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $422,347 - $493,862	4,267 Added 8.13%	56,726 $6.56 Million
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $150,569 - $159,240	-1,403 Reduced 2.6%	52,459 $5.73 Million
Q3 2022 Nov 08, 2022	SELL	$58.92 - $84.67 $309,624 - $444,940	-5,255 Reduced 8.89%	53,862 $3.33 Million
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $242,884 - $355,945	-3,059 Reduced 4.92%	59,117 $4.72 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $1.31 Million - $1.67 Million	15,169 Added 32.27%	62,176 $6.54 Million

Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $4.32 Million - $5.19 Million	47,007 New	47,007 $5.15 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Uss Investment Management LTD with notifications on news.